Related Experiment Video

Updated: Jul 2, 2025

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

1.1K

NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024

Robert J Motzer1, Eric Jonasch2, Neeraj Agarwal3

  • 11Memorial Sloan Kettering Cancer Center.

Journal of the National Comprehensive Cancer Network : JNCCN
|February 23, 2024
PubMed

Insights

The NCCN Guidelines for Kidney Cancer (Version 2.2024) offer updated recommendations for advanced renal cell carcinoma (RCC) systemic therapy. These insights highlight new clinical data for optimizing patient treatment strategies.

Area of Science:

  • Oncology
  • Clinical Guidelines

Background:

  • Renal cell carcinoma (RCC) is a significant cancer diagnosis.
  • Effective management of advanced RCC relies on up-to-date treatment protocols.

Purpose of the Study:

  • To summarize key updates in systemic therapy for advanced renal cell carcinoma (RCC).
  • To present the NCCN panel's evaluation of new clinical data for Version 2.2024.

Main Methods:

  • Review of recent clinical trial data relevant to advanced RCC.
  • Expert panel evaluation and guideline formulation by the National Comprehensive Cancer Network (NCCN).

Main Results:

  • The NCCN Guidelines for Kidney Cancer (Version 2.2024) incorporate new systemic therapy options.
  • Updated recommendations reflect the latest evidence for advanced RCC treatment.

Conclusions:

  • The NCCN Guidelines provide essential, evidence-based recommendations for advanced RCC management.
  • Version 2.2024 ensures clinicians have access to current, multidisciplinary treatment strategies.

More Related Videos

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

16.7K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
973
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89